SEC Filing Update: #INBX Inhibrx Biosciences, Inc. : $88.37

Sector: Healthcare | YTD: 🔼+ 18.05% The SEC disclosed Today (14-AUG-2026) that SCHONFELD STRATEGIC ADVISORS LL has INCREASED #INBX Shares by 12.05% 🟢 * Previous Holdings: 697.59K Shares * Current Holdings: 781.68K Shares * Increase+84.09K * Increased(%)+12.05% * Ownership: 5.33% * Estimated Investment Value: $7.52M https://www.thinksabio.com/reports/isr/INBX The quarterly average prices of #INBX: Q3 2025: $24.62 Q4 2025: $67.95 Q1 2026: $74.17 📌 Institutional activity in the last 30 days for #INBX: • BANK OF AMERICA CORP DE – Increased holdings by 824,635 shares (03-AUG-2026)